Feb 6 (Reuters) - Promis Neurosciences Inc PMN.TO :
* Promis Neurosciences announces private placement
* Promis Neurosciences Inc says it is offering, on a private placement basis, up to 14 million units at price of cdn$0.145 per unit
* Promis Neurosciences - net proceeds of offering will be used to advance co's alzheimer disease portfolio, including development of lead product PMN 310
* Promis Neurosciences - net proceeds to be used to initiate development of effective ad diagnostics for detection of toxic prion strains
* Promis Neurosciences Inc - net proceeds of offering will be used to develop Promis' TAU and TDP43 assets for dementias and ALS Source text for Eikon: ID:nCNWRL9GFa Further company coverage: PMN.TO